Notably, the Automated Insulin Delivery Amongst Pregnant Women With Type 1 Diabetes (AiDAPT; ClinicalTrials.gov Identifier: NCT04938557) trial in pregnant women with T1D, randomized to use the CamAPS FX system or a standard insulin pen or pump with a CGM, showed that participants using the CamAPS FX system spent an additional 2.5 h/day in range.16 The use of the CamAPS FX system during pregnancy also improved maternal and neonatal outcomes. Here, INS is linked to type 1 diabetes mellitus.